Xeris Biopharma Holdings Inc. buy Piper Sandler
Start price
10.05.24
/
50%
€1.64
Target price
10.05.25
€2.78
Performance (%)
35.94%
Price
24.07.24
€2.23
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Xeris Biopharma Holdings Inc. has seen massive gains of 35.94%. This prediction currently runs until 10.05.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Xeris Biopharma Holdings Inc. | -0.801% | -0.801% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Piper_Sandler for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Ratings data for XERS provided by MarketBeat
Stopped prediction by Piper_Sandler for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€1.60
10.11.23
10.11.23
€3.74
10.11.24
10.11.24
39.25%
24.07.24
24.07.24